AVR 0.99% $15.30 anteris technologies ltd

hsv2 final results, page-57

  1. 1,142 Posts.
    lightbulb Created with Sketch. 1
    There's actually also physical strain on the host in terms of gastrointestinal distress and liver distress over the long term. These drugs are quite safe, but this is still a factor.

    The reason, though, is that Genoceas vax isn't through all the hurdles yet, and bodies like the FDA don't care about stuff that isn't on market.

    But I get your point. As a race, I take Gens vax as the benchmark. But there's more to it than that. It's also the business acumen and the deal offered. I think we have a much better team from that POV now.
 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
(20min delay)
Last
$15.30
Change
0.150(0.99%)
Mkt cap ! $294.1M
Open High Low Value Volume
$15.35 $15.35 $15.00 $92.29K 6.09K

Buyers (Bids)

No. Vol. Price($)
1 50 $15.20
 

Sellers (Offers)

Price($) Vol. No.
$15.30 276 1
View Market Depth
Last trade - 16.10pm 31/07/2024 (20 minute delay) ?
AVR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.